Lepu Biopharma Statistics

Total Valuation

Lepu Biopharma has a market cap or net worth of HKD 5.46 billion. The enterprise value is 5.65 billion.

Market Cap	5.46B
Enterprise Value	5.65B

Important Dates

The next estimated earnings date is Thursday, November 21, 2024.

Earnings Date	Nov 21, 2024
Ex-Dividend Date	n/a

Share Statistics

Lepu Biopharma has 1.71 billion shares outstanding. The number of shares has increased by 0.31% in one year.

Current Share Class	n/a
Shares Outstanding	1.71B
Shares Change (YoY)	+0.31%
Shares Change (QoQ)	+0.64%
Owned by Insiders (%)	35.28%
Owned by Institutions (%)	6.69%
Float	645.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.10
PB Ratio	5.55
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-72.35
EV / Sales	25.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.80

Financial Position

The company has a current ratio of 0.75, with a Debt / Equity ratio of 0.86.

Current Ratio	0.75
Quick Ratio	0.64
Debt / Equity	0.86
Debt / EBITDA	n/a
Debt / FCF	-2.48
Interest Coverage	-28.83

Financial Efficiency

Return on equity (ROE) is -10.26% and return on invested capital (ROIC) is -17.06%.

Return on Equity (ROE)	-10.26%
Return on Assets (ROA)	-11.33%
Return on Capital (ROIC)	-17.06%
Revenue Per Employee	448,798
Profits Per Employee	-158,925
Employee Count	429
Asset Turnover	0.08
Inventory Turnover	1.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.40% in the last 52 weeks. The beta is -0.44, so Lepu Biopharma's price volatility has been lower than the market average.

Beta (5Y)	-0.44
52-Week Price Change	-14.40%
50-Day Moving Average	3.18
200-Day Moving Average	3.59
Relative Strength Index (RSI)	50.35
Average Volume (20 Days)	3,239,535

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Lepu Biopharma had revenue of HKD 220.36 million and -78.03 million in losses. Loss per share was -0.05.

Revenue	220.36M
Gross Profit	173.55M
Operating Income	-471.42M
Pretax Income	-91.72M
Net Income	-78.03M
EBITDA	-395.20M
EBIT	-471.42M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 629.89 million in cash and 832.61 million in debt, giving a net cash position of -202.72 million or -0.12 per share.

Cash & Cash Equivalents	629.89M
Total Debt	832.61M
Net Cash	-202.72M
Net Cash Per Share	-0.12
Equity (Book Value)	969.21M
Book Value Per Share	0.57
Working Capital	-259.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -312.00 million and capital expenditures -24.00 million, giving a free cash flow of -336.00 million.

Operating Cash Flow	-312.00M
Capital Expenditures	-24.00M
Free Cash Flow	-336.00M
FCF Per Share	-0.20

Full Cash Flow Statement

Margins

Gross margin is 78.76%, with operating and profit margins of -213.93% and -35.41%.

Gross Margin	78.76%
Operating Margin	-213.93%
Pretax Margin	-41.62%
Profit Margin	-35.41%
EBITDA Margin	-179.34%
EBIT Margin	-213.93%
FCF Margin	-152.48%

Dividends & Yields

Lepu Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.31%
Shareholder Yield	-0.31%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Lepu Biopharma has an Altman Z-Score of 0.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.46
Piotroski F-Score	n/a